140Nd-DOTA-LM3

N/A

Report date: 2025/11/20 16:03:54

Base Information

Drug Name140Nd-DOTA-LM3

Drug Alias Name140Nd-DOTA-LM3

ClassificationRadiation-emitting products > Nuclides > Neodymium > 140NdRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor antagonists

TargetsSomatostatin receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTechnical University Of Denmark

China Registration ClassN/A

Develop Information

Active CompaniesTechnical University Of Denmark

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A